Hutterer, Markus and Nowosielski, Martha and Putzer, Daniel and Jansen, Nathalie L. and Seiz, Marcel and Schocke, Michael and McCoy, Mark and Goebel, Georg and la Fougere, Christian and Virgolini, Irene J. and Trinka, Eugen and Jacobs, Andreas H. and Stockhammer, Guenther (2013) [F-18]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. NEURO-ONCOLOGY, 15 (3). pp. 341-351. ISSN 1522-8517,
Full text not available from this repository. (Request a copy)Abstract
Background. To assess the sensitivity and specificity of [F-18]-fluoro-ethyl-L-tyrosine (F-18-FET) PET in brain tumors and various non-neoplastic neurologic diseases. Methods. We retrospectively evaluated F-18-FET PET scans from 393 patients grouped into 6 disease categories according to histology (n = 299) or distinct MRI findings (n = 94) (low-grade/high-grade glial/nonglial brain tumors, inflammatory lesions, and other lesions). F-18-FET PET was visually assessed as positive or negative. Maximum lesion-to-brain ratios (LBRs) were calculated and compared with MRI contrast enhancement (CE), which was graded visually on a 3-point scale (no/moderate/intense). Results. Sensitivity and specificity for the detection of brain tumor were 87% and 68%, respectively. Significant differences in LBRs were detected between high-grade brain tumors (LBR, 2.04 +/- 0.72) and low-grade brain tumors (LBR, 1.52 +/- 0.70; P < .001), as well as among inflammatory (LBR, 1.66 +/- 0.33; P = .056) and other brain lesions (LBR, 1.10 +/- 0.37; P < .001). Gliomas (n = 236) showed F-18-FET uptake in 80% of World Health Organization (WHO) grade I, 79% of grade II, 92% of grade HI, and 100% of grade IV tumors. Low-grade oligodendrogliomas, WHO grade II, had significantly higher F-18-FET uptakes than astrocytomas grades II and Ill (P = .018 and P = .015, respectively). F-18-FET uptake showed a strong association with CE on MRI (P < .001) and was also positive in 52% of 157 nonglial brain tumors and nonneoplastic brain lesions. Conclusions. F-18-FET PET has a high sensitivity for the detection of high-grade brain tumors. Its specificity, however, is limited by passive tracer influx through a disrupted blood brain-barrier and F-18-FET uptake in nonneoplastic brain lesions. Gliomas show specific tracer uptake in the absence of CE on MRI, which most likely reflects biologically active tumor.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMA; CONTRAST-ENHANCING GLIOMAS; FET-PET; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; CEREBRAL GLIOMAS; BRAIN-TUMORS; AMINO-ACID; F-18-FET PET; MRI; F-18-FET PET; diagnostic value; glioma; MM; brain tumor |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Neurologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 23 Apr 2020 13:27 |
| Last Modified: | 23 Apr 2020 13:27 |
| URI: | https://pred.uni-regensburg.de/id/eprint/17079 |
Actions (login required)
 |
View Item |
